Usefulness of Homoeopathic medicine in Bipolar affective disoder

Effectiveness of Individualized Homoeopathic Medicine in Reducing Irritability in Bipolar 1 Disorder - A Single Arm Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061059

Enrollment

Registered

2024-01-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F31- Bipolar disorder

Interventions

Intervention1: Individualized Homoeopathic Medicines: Totality of the symptoms shall be constituted after the case taking. The symptoms will be repertorized using the suitable repertory in RADAR Opus

Eligibility

Inclusion criteria

Inclusion criteria: 1.Ages from 18 to 65 years, both sexes who have fulfilled the DSM V criteria for Bipolar 1 disorder. 2.Bipolar 1 disorder with or without psychotic symptoms

Exclusion criteria

Exclusion criteria: 1. Patients with suicidal risks, 2. Pregnant and lactating women, 3. Chronic severe Medical Illness.

Design outcomes

Primary

Measure	Time frame
Cases will be assessed with Born Steiner Irritability scale (BSIS), and Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD)Timepoint: The Born Steiner Irritability scale (BSIS) will be used to assess the cases at the Baseline and every month till the conclusion of the study. The Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD) will be used to assess the cases at the Baseline and every three months till the conclusion of the study.	—

Measure

Time frame

Cases will be assessed with Born Steiner Irritability scale (BSIS), and Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD)Timepoint: The Born Steiner Irritability scale (BSIS) will be used to assess the cases at the Baseline and every month till the conclusion of the study. The Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD) will be used to assess the cases at the Baseline and every three months till the conclusion of the study.

—

Secondary

Measure	Time frame
The reduction in frequency of episodes of irritability in Bipolar 1 disorder will be assessed using Born Steiner Irritability scale (BSIS).Timepoint: Cases will be assessed with Born Steiner Irritability scale (BSIS), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.;The reduction in intensity of irritability in subsequent episodes of Bipolar 1 disorder will be assessed using Born Steiner Irritability scale (BSIS).Timepoint: Cases will be assessed with Born Steiner Irritability scale (BSIS), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.;The reduction of symptoms of Bipolar 1 disorder will be assessed using SAEBD scale.Timepoint: Cases will be assessed with Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.	—

Measure

Time frame

The reduction in frequency of episodes of irritability in Bipolar 1 disorder will be assessed using Born Steiner Irritability scale (BSIS).Timepoint: Cases will be assessed with Born Steiner Irritability scale (BSIS), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.;The reduction in intensity of irritability in subsequent episodes of Bipolar 1 disorder will be assessed using Born Steiner Irritability scale (BSIS).Timepoint: Cases will be assessed with Born Steiner Irritability scale (BSIS), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.;The reduction of symptoms of Bipolar 1 disorder will be assessed using SAEBD scale.Timepoint: Cases will be assessed with Scale for the Assessment of Episodes in Bipolar Disorder (SAEBD), at the baseline, 3rd, 6th, 9th month and at the conclusion of the study.

—

Countries

India

Contacts

Public ContactDr M Gnnanaprakasham

National Homoeopathy Research Institute in Mental Health

drgprakashpsy@gmail.com9444701176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026